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Damage to the central nervous system (CNS) is one of the leading causes ofmorbidity andmortality in elderly, as repair after lesions
or neurodegenerative disease usually fails because of the limited capacity of CNS regeneration. The causes underlying this limited
regenerative potential are multifactorial, but one critical aspect is neuroinflammation. Although classically considered as harmful,
it is now becoming increasingly clear that inflammation can also promote regeneration, if the appropriate context is provided. Here,
we review the current knowledge on how acute inflammation is intertwined with axonal regeneration, an important component of
CNS repair. After optic nerve or spinal cord injury, inflammatory stimulation and/or modification greatly improve the regenerative
outcome in rodents. Moreover, the hypothesis of a beneficial role of inflammation is further supported by evidence from adult
zebrafish, which possess the remarkable capability to repair CNS lesions and even restore functionality. Lastly, we shed light on the
impact of aging processes on the regenerative capacity in the CNS of mammals and zebrafish. As aging not only affects the CNS,
but also the immune system, the regeneration potential is expected to further decline in aged individuals, an element that should
definitely be considered in the search for novel therapeutic strategies.
1. Introduction
Brain injuries and neurodegenerative disorders, such as Alz-
heimer’s and Parkinson’s disease, multiple sclerosis, or glau-
coma, represent a growing social and economic burden and
affect an increasing number of people in our aging society.
Traumatic lesions and neurodegeneration drastically reduce
life quality and lead to severe and often fatal impairments,
largely because the central nervous system (CNS) of adult
mammals retains only little capacity for regeneration into
adulthood, which comprises the replacement of lost neurons
(de novo neurogenesis) and/or the repair of damaged axons
(axonal regeneration) [1, 2]. The lack of long-distance axonal
regeneration in the mature mammalian CNS, on which will
be focused here, has been attributed to an insufficient intrin-
sic growth capacity of its neurons and an inhibitory extrinsic
environment [3, 4]. Our current knowledge of the underlying
molecules and pathways mainly comes from two well
characterized rodent injury models: optic nerve and spinal
cord lesions. Damage to the optic nerve, which solely consists
of axons originating from the retinal ganglion cells (RGC)
located in the inner retina, results in apoptotic RGCdeath and
consequently in vision loss [5–7]. Preservation of injured cells
followed by axonal regeneration can be stimulated, both by
intrinsic and by extrinsic factors, but full functional recovery
has not yet been achieved [8–10]. Spinal cord injuries lead
to death of the damaged cells at the epicenter of the lesion,
including neurons, oligodendrocytes, and astrocytes. After
the primary insult, secondary processes (excitotoxicity, oxi-
dative stress, etc.) may cause additional loss of neurons and
supporting cells. Furthermore, interrupted descending and
ascending axonal tracts have debilitating consequences, and
although proximal segments typically survive, they do not
regenerate spontaneously [11–13]. Restoration of motor and
sensory tracts via axonal regeneration is believed to be the
most promising way to reverse paralysis after spinal cord
injury [14]. Regenerative strategies known thus far, as well
as identified intracellular pathways and growth-inhibiting
factors, are largely similar to those characterised in optic
nerve regeneration [15, 16].
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In mammals, the acute inflammatory response that takes
place rapidly after traumatic CNS lesions is put forward as
one of the major elements affecting the regenerative outcome
[17]. Microglia, the main mediators of inflammation in the
CNS, are among the first cells to respond to damage. They
become activated, thereby changing their morphology from
ramified to amoeboid, proliferate, migrate to the injury site,
and start to produce a variety of pro- and anti-inflammatory
cytokines [18]. Furthermore, neutrophils and macrophages
from the periphery are recruited to the injured area, and,
togetherwith reactive astrocytes,microglia/macrophageswill
contribute to the formation of a regeneration-inhibiting glial
scar [4, 19]. Traditionally, the acute inflammatory response
has been viewed as a detrimental orchestrator inCNSdamage
and pathology. After spinal cord injury, depletion of
peripheral macrophages enhances axonal regeneration and
improves functional recovery [20]. Administration of the
anti-inflammatory drug minocycline gives similar results
[21]. However, more recent evidence suggests that the inflam-
matory response can also positively contribute to regenera-
tion [22, 23], as is exemplified by an improved behavioural
outcome after spinal cord injury resulting from an increased
number of monocyte-derived macrophages via adoptive
transfer [24]. These conflicting results have led to substantial
controversy regarding the negative or positive effect of acute
inflammation in CNS regeneration. Ongoing and future
investigations of its mediator cells and their key regulatory
switches thus seem to be essential for a better understanding
of how successful regeneration can be induced.
In sharp contrast to mammals, adult zebrafish are capable
of extensive and successful regeneration throughout their
body, including their fins, heart, liver, and CNS [25, 26].
This has sparked the interest of many neuroscientists, who
turned to this small laboratory animal to understand the
crucial molecules underlying successful CNS repair. Adult
zebrafish retain the capacity of robust axonal regeneration
and canmorphologically and functionally recover from optic
nerve and spinal cord injuries [27]. Moreover, similar to
the situation in mammals, an acute inflammatory response
occurs after CNS injury in zebrafish, which has recently been
suggested to positively contribute to the regenerative process
[28, 29]. Given the high degree of conservation between
teleosts andmammals at both themolecular and genetic level,
research in zebrafish can help to overcome the limitations of
nonregenerative mammalian models, in which the regener-
ative outcome is always suboptimal, even when stimulated
[25]. A thorough understanding of how zebrafish can couple
acute inflammation to successful regeneration after injury
may thus contribute to the development of regenerative
therapies.
Since neurodegenerative diseases are age-related, regen-
erative therapies will often need to be achieved in the senes-
cent CNS. Therefore, the effect of aging on the regenerative
potential should not be overlooked. Indeed, aging processes
affect CNS functioning, as is evidenced by, for instance, a
reduced synaptic efficacy and neuronal loss in the senescent
CNS [30, 31], and may further deteriorate the already poor
regenerative outcome. Notably, also the immune system
is subjected to aging [32–34], which may complicate its
functioning during regeneration after CNS injuries. Despite
its relevance, the impact of immune senescence on the regen-
erative capacity in the aged CNS remains poorly understood.
Also in zebrafish, which has recently been established as a
valuable model for human CNS aging [35], in-depth charac-
terization of the interplay between acute inflammation and
axonal regeneration in an aging context is still lacking.
This review aims at providing an overview of the current
understanding of how inflammatory factors modify the
regenerative outcome after damage in the adult CNS, in both
mammals and zebrafish, thereby focusing on microglia and
macrophages. Moreover, the effect of aging on inflammatory
cell physiology and the implications this may have on the
regenerative capacity will be discussed.
2. Acute Inflammation Promotes Axonal
Regeneration in Mammals
Over the past decades, intensive research efforts have focused
on the discovery of novel targets of whichmanipulation could
enable regeneration after CNS trauma. Modulation of the
acute inflammatory response has been proposed as promising
strategy to induce axonal regeneration. Compelling evidence
for a beneficial influence of different aspects of neuroinflam-
mation has been gathered in various brain injury models [17,
36, 37].Here, wewill focus on the role of inflammation during
axonal regeneration after optic nerve and spinal cord injuries.
2.1. Inflammatory Stimulation Improves the Regenerative Out-
come. Stimulation of inflammation has proven to be one
of the pivotal factors to induce a regenerative response in
mammalian axonal regeneration models. For optic nerve
injury, early studies have shown that a peripheral nerve graft,
lens injury, or intravitreal injection of zymosan, a proinflam-
matory glucan molecule derived from the yeast cell wall, can
induce RGC axon growth in rodents [38–41]. More recently,
the smaller molecule Pam
3
Cys, which acts on the Toll-like
receptor 2 (TLR2), is shown to stimulate axonal regeneration
as well [42, 43]. All these experimental procedures induce
activation of retinal micro- and macroglia and are accompa-
nied by an influx of neutrophils andmacrophages to the vitre-
ous.Therefore, these treatments can collectively be referred to
as “inflammatory stimulation” [4, 43].
Similarly, inflammatory stimulation improves the regen-
erative outcome after spinal cord injury. For example,
intraspinal injection of zymosan increases axon growth [44],
and stimulation with Pam2CSK4, another TLR2 agonist, was
found to reduce axonal loss after spinal cord injury. This
neuroprotection is a prerequisite for growth cone formation
and subsequent axonal regeneration [45].Thus,multiple lines
of evidence point towards a positive effect of inflammation
on (neuroprotection and) axonal regeneration of damaged
neurons. However, in order to gain a better understanding
of this process, detailed characterization of the nature of
inflammatory mediators is indispensable.
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2.2. Mediators of Inflammation in Optic Nerve Regeneration
2.2.1. Inflammatory Events at the Injury Site. Similar to other
CNS lesions, acute damage to the optic nerve causes changes
in the microenvironment directly surrounding the site of
the injury. Myelin, which is normally wrapped around the
axons, becomes fragmented, leaving the axon tips exposed to
myelin-derived inhibitory molecules such as Nogo, myelin-
associated glycoprotein (MAG), and oligodendrocyte-myelin
glycoprotein (OMgp) [4, 7]. Very soon after the injury, res-
ident microglia become reactivated and monocyte-derived
macrophages are recruited to the lesion site. Microglia are
involved in the reactivation of astrocytes, as they start
secreting various cytokines and other factors [46]. Eventually,
these glial cells all contribute to the formation of scar tissue,
which represents an important barrier to regenerating axons
[4, 47]. Furthermore, the actions of microglia/macrophages
as well as astrocytes have been suggested to lead to the
propagation of secondary degeneration, which contributes to
spreading of damage beyond the initial (primary) lesion site
[48, 49]. Alternatively,microglia/macrophages have also been
suggested to exert beneficial functions at the lesion site, such
as phagocytosis of myelin debris or protection against gluta-
mate excitotoxicity. The outcome of microglial/macrophage
activation, whether positive or negative, is supposed to be
highly dependent on the timing and the precise pathological
conditions [49, 50] and thus needs further elucidation.
2.2.2. Inflammatory Events in the Retina. Injury to the optic
nerve induces acute inflammatory processes not only at the
epicenter of the lesion, but also in the retina, where the RGC
cell somata reside. Since stimulation of inflammation in the
optic nerve as well as in the eye can protect RGCs, but only
the latter promotes axonal regeneration [51], paradigms of
inflammatory stimulation focus on altering retinal events.
After optic nerve injury, the resident retinal microglia
respond rapidly, which can be considered a primary event
resulting from the injury. However, microglial reactivation in
the retina has also been linked to secondary degeneration of
RGCs, although its exact role is unclear [49]. Yet, microglial
reactivation does not occur uniformly across the retina. In
the naive adult retina, surveying microglia are mainly found
in four layers: the nerve fibre layer (NFL), the ganglion
cell layer (GCL), and the inner and outer plexiform layers
(IPL and OPL, resp.) [52, 53]. Upon injury, microglia in
the OPL remain almost unaffected, while their cell number
is increased and morphology is switched from ramified to
amoeboid in the inner retinal layers, and most prominently
in the GCL [53, 54]. In adult rats, microglial cell numbers
augment dramatically from 3 days to 3 weeks after injury and
return to almost normal levels by 6 weeks [53]. This increase
coincides with the period during which RGC death occurs
in response to the injury [5, 52, 53], and microglia actively
phagocytize the debris from these RGCs and their axons [52–
54]. Notably, the increase in glial cell number after optic
nerve injury may either originate from local proliferation
or from infiltration of blood-derived macrophages [53], but
as it is very difficult to discriminate between these two cell
populations [24], the relative contribution of both processes
remains unclear.
Interestingly, microglial activation is also observed in
the contralateral, uninjured eye. Although the increase in
microglial density is not as high as in the ipsilateral retina and
is mostly confined to the central retina, clear morphological
changes can be observed [52, 53]. This suggests microglial
activation in both eyes upon unilateral optic nerve damage,
pointing towards cross-talk between both eyes, whichmay be
orchestrated via the optic chiasm or hematogenous transfer-
ence [53, 55]. Yet, its physiological function remains to be elu-
cidated. Of note, this finding then also clearly indicates that
the use of the contralateral eye as an internal control in retinal
de- and regeneration studies should be reconsidered [53].
Next to the reactivated amoeboid microglia, another
unique, so-called rod microglial morphology has recently
been described in the mouse retina after optic nerve injury
[56]. Rod microglia are first discovered after injury in the
brain cortex [57] and are also described in the retina in a laser-
induced ocular hypertension model for glaucoma [58, 59].
After optic nerve injury, the rod microglia are present from
day 7 and are completely gone by 6 weeks.They are suggested
to form the major group of phagocytic cells in the retina
during this time [56].
The functional role of resident microglia in neuropro-
tection and axonal regeneration after optic nerve injury has
not yet been studied in detail. Instead, most attention has
been given to the role of retinal macroglia (mostly astrocytes)
on the one hand and infiltrating leukocytes (neutrophils and
macrophages) on the other hand. Nevertheless, some debate
exists on their relative importance. Firstly, axonal regenera-
tion can be stimulated via intravitreal injection of zymosan,
which causes the infiltration of neutrophils andmacrophages.
These cells may in turn serve as a source for oncomodulin, a
small calcium-binding protein that has been suggested to
be one of the major mediators of the beneficial effect of
the intraocular inflammation on axonal regeneration (Fig-
ure 1(a)). Its function is dependent on the presence of cAMP
and mannose [60–62] and thought to result from its binding
to a high-affinity receptor on RGCs [60, 63]. Administration
of a peptide competing for oncomodulin receptor binding
was found to prohibit axon growth after optic nerve injury
in mice [16, 61, 63]. Furthermore, combined deletion of
dectin-1 and TLR2, both coding for pattern recognition
receptors expressed by inflammatory cells and necessary to
respond to inflammatory stimulation, completely abolishes
the regeneration-promoting effect of zymosan, again point-
ing towards the importance of immune mediators in axonal
regeneration [64].
Second, inflammatory stimulation also induces the
release of cytokines from activated retinal macroglia. Three
cytokines from the IL-6 superfamily, namely, ciliary neu-
rotrophic factor (CNTF), leukemia inhibitory factor (LIF),
and IL-6, have been proposed as key mediators of the stim-
ulating effect of inflammation on optic nerve regeneration
[4, 65, 66] (Figure 1(a)). Indeed, the neuroprotective and
axon growth stimulating effects of inflammatory stimulation
are diminished in CNTF knock-out mice and abolished
in CNTF/LIF double knock-out mice, thereby ascribing a















































Figure 1: Summary of the current knowledge of the role of acute inflammation in axonal regeneration, in mammals and zebrafish. (a)
After optic nerve injury in mammals, surveying retinal microglia become reactivated, proliferate, and transform into amoeboid microglia.
Inflammatory stimulation (green arrows), which can be achieved via administration of TLR2 agonists or lens injury, further induces micro-
and macroglial cell activation and an influx of neutrophils and blood-borne macrophages to the vitreous. Infiltrating macrophages and
neutrophils secrete oncomodulin (Ocm), an inflammatory mediator that is thought to act on RGCs directly. Moreover, inflammatory
stimulation elicits the secretion of IL-6 family cytokines from reactive astrocytes. Signal transduction of these cytokines is primarily mediated
via the JAK/STAT3 and mTOR pathways in RGCs. Thus, inflammatory stimulation activates the intrinsic growth state of RGCs, and when
combined with SOCS3 and/or PTEN deletion, feedback inhibitors of the JAK/STAT3 and mTOR pathway, respectively, axon regeneration
beyond the glial scar can be obtained. (b) After an injury in the mammalian spinal cord microglia are activated, and neutrophils and
blood-borne macrophages are recruited to the lesion site. Microglia/macrophages mostly adopt the proinflammatory phenotype and secrete
proinflammatory cytokines such as TNF-𝛼 and IL-1𝛽, while anti-inflammatory microglia/macrophages, which produce anti-inflammatory
cytokines including IL-4 and IL-10, only represent a small percentage. Since the proinflammatory type is associated with adverse effects on
regeneration, while anti-inflammatory cells are assumed to be protective and growth-promoting, treatments that stimulate anti-inflammatory
activation at the expense of the proinflammatory type (green arrows) improve axonal growth beyond the glial scar and coincide with a better
regenerative outcome. (c) Stimulation of acute inflammation after optic nerve injury in zebrafish activates microglia and induces recruitment
of neutrophils and blood-borne macrophages, mirroring the situation in mammals. This results in an acceleration of the spontaneous
regenerative process. Although it has already been shown that LIF and the JAK/STAT3 and mTOR pathways are implicated in optic nerve
regeneration in zebrafish as well, the precise mechanism of how the positive effects of acute inflammation is mediated remains elusive. (d)
After a spinal cord injury in zebrafish,microglia are activated and neutrophils and blood-bornemacrophages infiltrate the lesion site, although
their precise contribution to axonal regeneration is still unknown. Despite pro- and anti-inflammatory macrophages have been described
in zebrafish injury models outside the CNS, the polarization of microglia/macrophages after spinal cord injury has not yet been studied.
Strikingly, a growth-permissive glial bridge is formed at the lesion site, while glial scar is absent in zebrafish.
principal role toCNTF,with LIF as an additional contributing
factor [65]. Of note, direct intravitreal administration of
CNTFhas only limited effects on axonal regeneration, yet this
might be explained by the short half-life of the protein in the
vitreous [40, 67, 68]. The continuous release of CNTF and
LIF by astrocytes after inflammatory stimulation, ensuring
prolonged supply to RGCs, can be mimicked via AAV-
mediated expression of CNTF in RGCs [69–71] or in Mu¨ller
glia [72]. This viral CNTF expression has stronger effects on
neuroprotection and axonal regeneration than those achieved
via intravitreal injection, eliciting long-distance regrowth of
axons up to the optic chiasm, but rarely beyond [1, 72].
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Altogether, these studies clearly indicate that this group of
cytokines plays a determining role in optic nerve regenera-
tion. To date, however, the relative importance of oncomodu-
lin, CNTF, LIF, IL-6, and other inflammatory factors has not
yet been fully elucidated.
The importance of acute inflammation as a positive deter-
minant in optic nerve regeneration is also reflected in some
of the downstream molecular mechanisms and pathways
identified thus far. Signal transduction of IL-6 superfamily
cytokines is primarily mediated via the Janus Kinase/Signal
Transducers and Activators of Transcription (JAK/STAT)
pathway, which has been identified as an important positive
player in optic nerve regeneration. The protein suppressor of
cytokine signaling 3 (SOCS3), a feedback inhibitor of the
JAK/STAT pathway, has counteracting effects on axon regen-
eration after optic nerve injury. Accordingly, deletion of the
SOCS3 gene markedly enhances axon growth and improves
the regenerative outcome of intravitreal CNTF administra-
tion [4, 10, 73]. Consistently, AAV-mediated overexpression
of SOCS3 in RGCs almost completely abolishes RGC regen-
eration and suppresses the otherwise neurotrophic effect
of intravitreal CNTF administration [74]. Of note, it has
been shown that SOCS3 expression can be counteracted be
delivering cAMP [75], whichmight explain the positive effect
of elevating cAMP levels on axonal regeneration induced
by inflammatory stimulation [4, 76]. Deletion of SOCS3,
combinedwith a deletion of phosphatase and tensin homolog
(PTEN), an upstream inhibitor of the mammalian target of
rapamycin (mTOR) pathway that is also repeatedly shown to
inhibit axonal regeneration, whether or not in combination
with inflammatory stimulation [76–78], has been reported to
induce a remarkable regenerative response [8–10, 76]. One
study that uses PTEN deletion in combination with zymosan
and a cAMP analog even reports scanty reinnervation of
visual brain areas, including the lateral geniculate nucleus
and the superior colliculus, and partial visual recovery [8].
Recently, it has also been shown that enhancing neural activ-
ity of RGCs via visual stimulation or chemogenetics, in com-
bination with stimulation of mTOR activity by overexpress-
ing the positive regulator Ras homolog enriched in brain
1 (Rheb1), enables long-distance and target-specific RGC
axonal regeneration. This is accompanied by partial restora-
tion of visual function [79]. Furthermore, continuous AAV-
driven expression of hyper IL-6 cytokine (hIL-6), a designer
cytokine that consist of the covalently linked bioactive parts
of IL-6 and IL-6R𝛼, in RGCs has been recently described
as the most potent unifactorial treatment to promote axonal
regeneration known thus far. When combined with PTEN
deletion, hIL-6 improves optic nerve regeneration even
more, with some axons reaching the chiasm within 3 weeks
after optic nerve injury [78]. Conclusively, novel therapeutic
approaches based on recent insights in the beneficial role
of inflammatory mediators in regenerative processes hold
exciting promise.
2.3. Mediators of Inflammation in Spinal Cord Regeneration
2.3.1. Inflammatory Events at the Injury Site. Similar to
other CNS injuries, damage to the spinal cord is followed
by an acute inflammatory response. Resident microglia are
activated, and neutrophils, macrophages, and lymphocytes
infiltrate the lesion site. Also here, this inflammatory reaction
eventually becomes chronic, and reactive astrocytes form a
regeneration-inhibiting glial scar [19, 80, 81]. In the search
for the exact contribution of inflammation to the regenerative
potential, most studies in the field of spinal cord regeneration
have focused on the role of microglia and blood-borne
macrophages. Resident microglia are the first to respond to
the injury, and infiltrating macrophages reach the injury site
during the following days [82–86]. Most of these monocyte-
derived macrophages originate from the spleen, while only a
minority is mobilized from the bone marrow reservoir [86].
It has been proposed that different states of microglia/
macrophage activation may influence the repair process
[87]. Indeed, monocyte-derived macrophages polarize into
different phenotypes, which are determined by the microen-
vironment and may change in response to new stimuli [88].
These functional states are generally divided into two main
classes, based on the activation pathway, known as the “clas-
sically activated” proinflammatory M1 macrophages and the
“alternatively activated” anti-inflammatoryM2macrophages.
Later, additional subtypes of M2 (M2a, M2b, and M2c) have
been described. However, macrophage activation is far more
diverse than these simple categories. As such, theM1/M2phe-
notypes rather represent two extreme poles, with in between
a whole spectrum of activation states with overlapping prop-
erties [89–92]. A similar polarization has also been described
for microglia [18]. Although there is now a general consen-
sus that this M1/M2 classification of microglia/macrophage
activation is an oversimplification, it nevertheless persists as
a conceptual framework to facilitate our understanding of
microglia/macrophage function [93].
After spinal cord injury, proinflammatory,M1-likemacro-
phages are associated with secondary tissue damage, neu-
ronal loss, axon retraction and demyelination, while anti-
inflammatory, M2-like macrophages are assumed to be
protective and promoting axon growth. In this regard, the
balance between pro- and anti-inflammatory macrophages
could be a major factor determining the regenerative out-
come [19, 23]. Indeed, it has been demonstrated that most
microglia/macrophages in the injured spinal cord display an
M1-like activation state, with only a limited and transient
presence of M2-like cells. Moreover, evidence suggests that
lesion-derived factors (cytokines, chemokines, etc.) affect
the microglial/macrophage phenotype, thereby favouring the
proinflammatory state [94]. Therefore, it has been hypothe-
sized that shifting macrophage activation towards the anti-
inflammatory state may improve the regenerative outcome,
mirroring successful tissue repair responses such as those
occurring after skin or muscle injuries [87]. Some recent
studies have indeed provided evidence for the beneficial
effect of an augmented number of M2-like macrophages. For
example, transfer of in vitro polarized M2-like macrophages
to the damaged spinal cord improves functional recovery.
Notably, this transfer of M2-like cells is suggested to alter
the local microenvironment, thereby promoting the anti-
inflammatory state [95]. Moreover, blocking of the IL-6 sig-
naling pathway, via inhibition of the IL-6 receptor, results in
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an increase inM2-likemicroglia/macrophages at the expense
of the M1-like type. Indeed, this treatment inhibits classical
activation and promotes the alternative pathway and is
accompanied by an improved functional recovery [96]. Taken
together, these studies suggest that promoting alternative
microglial/macrophage activation is a promising strategy to
induce spinal cord regeneration (Figure 1(b)). Of note, it has
been argued that activated microglia and monocyte-derived
macrophages form functionally distinct, nonredundant cell
populations after spinal cord injury and do not contribute
equally to the repair process. As such, it has been suggested
that microglia rather than infiltrating macrophages unequiv-
ocally express markers for the pro- or anti-inflammatory
phenotype [86].Moreover, the beneficial secretion of the anti-
inflammatory cytokine IL-10 is attributed to (a subset of)
infiltrating macrophages but cannot be provided by the acti-
vated resident microglia [24]. Yet, the relative contribution of
microglia and macrophages still needs further clarification.
2.3.2. Inflammatory Events at the Cell Soma of the Injured
Neurons. Similar to the visual system, one should not only
consider acute inflammation at the injury site itself but also
turn to the cell soma of the axotomised neurons. However,
the spinal cord is a much more complex structure than the
optic nerve. While the latter only consists of RGC axons, the
spinal cord is a well organised structure comprising neurons
and axons of different types [97]. The cell bodies of the axo-
tomised axons after spinal cord injury thus reside at different
locations, challenging an unequivocal study of the inflamma-
tory events that are provoked there. It has been repeatedly
shown that spinal cord injuries induce widespread microglial
activation in different brain areas, also outside the regions
where the cell bodies of descending axon tracts are located
[98–100]. However, this has mostly been associated with
cognitive impairments and neuropathic pain as a result of the
injury and not yet to regenerative processes. Thus, whether
modification of these inflammatory responses would con-
tribute to enhanced regeneration of the spinal cord remains
elusive.
3. Successful Coupling of Neuroinflammation
and CNS Regeneration in Zebrafish
Since adult zebrafish are capable of functional recovery after
many CNS injuries, including optic nerve and spinal cord
damage [27], they provide an attractive approach to study
the interplay of inflammatory processes and CNS repair in
a regenerative-supporting setting. Research inmammalsmay
benefit from comparative studies in zebrafish. Amongst other
advantages, this species provides an example of how acute
inflammation can be linked to successful axonal regeneration.
Importantly, the zebrafish immune system is highly com-
parable to its mammalian counterpart. The major immune
cell lineages have been identified in zebrafish, and many
of the immune receptor classes, signaling pathways, and
inflammatory mediators are conserved as well [101].
3.1. Acute Inflammation in Zebrafish Optic Nerve Regenera-
tion. Also in zebrafish, optic nerve injury models are well
established.However, in contrast tomammals, inwhich a vast
number of RGCs undergo apoptosis after optic nerve injury
[5, 102], the large majority of their zebrafish counterparts
seem protected and do survive the lesion [103, 104]. In a
subsequent regenerative process, the damaged RGCs regrow
their axons and reinnervate the target areas in the brain, of
which the optic tectum is by far themost important [105–107].
The reestablished synaptic contacts are remarkably accurate
and visual function eventually recovers, as shown by means
of various vision-guided behavioural assays [27, 104].
Although the flawless regenerative responses after optic
nerve injury in zebrafish are well known, the underlying
cellular and molecular bases are less well understood. Never-
theless, analysis of gene expression patterns after optic nerve
injury has already provided a framework for further func-
tional studies [108, 109], and recent efforts have started to
uncover the regulating mechanisms (recently reviewed by
[110]). Noteworthy, no glial scar tissue is formed at the injury
site. This may be attributed to the presumed absence of
astrocytes in zebrafish. Instead, radial glial cells are assumed
to take over at least part of the functions ofmammalian astro-
cytes throughout the zebrafish CNS. Thus, the absence of a
regeneration-inhibiting glial upon injury, may to some extent
be explained by the functional differences between mam-
malian astrocytes and zebrafish radial glia [111].
Of importance, there is evidence to support the hypothe-
sis that acute retinal neuroinflammation might provide the
right context for the initiation of a regenerative response.
Firstly, an acute inflammatory response is observed after optic
nerve crush in fish, which has been suggested to positively
contribute to regeneration. More specifically, the number of
microglia/macrophages in the retina increases significantly
from 3 days after optic nerve crush onwards but is resolved
around 3 weeks after the injury [103]. Furthermore, intravit-
real application of zymosan, which results in a massive num-
ber of neutrophils and microglia/macrophages in the retina,
efficiently stimulates optic nerve regeneration in zebrafish-
[103] (Figure 1(c)). Of note, application of zymosan has been
associated with folding and retinal detachment of the mouse
retina [112]. Although this cannot completely be ruled out,
these effects have not been reported in zebrafish. In our
laboratory, we have been able to confirm the positive effect
of intravitreal zymosan injection on the regenerative process.
Zymosan administration 3 days prior to optic nerve injury
highly stimulated RGC axonal regeneration, assessed at 7
days after injury via anterograde biocytin tracing as described
previously [113, 114]. Indeed, reinnervation of the optic tec-
tum was found to be significantly increased in the zymosan-
treated group, indicating that inflammatory stimulation
accelerated the regenerative response after optic nerve injury
in zebrafish (Figure 2). Thus, also in zebrafish inflammatory
cells seem to have extensive effects on regeneration.
Second, recent evidence indicates that also in zebrafish
the IL-6 cytokine superfamily stimulates axonal regeneration
in an autocrine/paracrine manner, where especially LIF,
rather than CNTF or IL-6, seems to be involved. LIF is upreg-
ulated upon injury in the fish retina and suggested to play a
beneficial role in the early phase of the regenerative process
[115, 116]. Strikingly and similar to mammals, endogenous
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Figure 2: Intravitreal injection of zymosan accelerates axonal regeneration in zebrafish. (a) Representative images of biocytin-labeled axons
in the contralateral optic tectum of naive fish (left) and fish treated with vehicle or zymosan, at 7 days after optic nerve injury (middle and
right, resp.). The stratum opticum (SO), the layer through which the RGC axons innervate the tectum, is indicated. Scale bar = 50𝜇m. (b)
Quantification of the reinnervated area of the optic tectum in fish treated with vehicle or zymosan at 7 days after injury, relative to naive
fish. Intravitreal injection of zymosan significantly accelerates reinnervation, which is already close to naive levels in zymosan treated fish as
compared to vehicle-injected fish. Data represent mean ± SEM (𝑛 ≥ 3 animals per group, ∗𝑝 < 0.05, and ∗∗𝑝 < 0.01).
expression of zebrafish Socs3a also counteracts regenera-
tion after optic nerve injury, as is evidenced by enhanced
RGC axonal regeneration after Socs3a knockdown. However,
despite the activation of this inhibitory pathway, zebrafish
still possess the ability of robust axonal regeneration [115].
Furthermore, inhibiting mTOR activity compromises optic
nerve regeneration. This indicates a supportive role for
mTOR, although it seems ancillary rather than essential for
zebrafish axonal regeneration [117]. Clearly, factors counter-
acting regeneration are not absent in zebrafish, yet evolution
seems to have provided them with a way to overcome these
inhibitory mechanisms. The key to successful regeneration
in mammals may thus reside in finding a proper balance
between growth inhibition and stimulation [1, 110].
3.2. Acute Inflammation in Zebrafish Spinal Cord Regenera-
tion. Models to study spinal cord regeneration are well devel-
oped in adult zebrafish, where, again, damage to the spinal
cord is followed by a spontaneous regeneration process. After
a complete spinal cord transection, a growth-permissive glial
cell bridge is formed between the rostral and caudal lesion site
[118] and, by two weeks after injury, cerebrospinal axons have
started to regenerate beyond the transection site. This axonal
regeneration correlates with functional recovery, and most
fish regain their swimming abilities by five to eight weeks
after injury [27, 119]. Of note, the regenerative potential is not
equal for all axons in the spinal cord, as some axon types show
only poor regrowth [27]. Apart from axonal regeneration,
regenerative neurogenesis has also been described after spinal
cord injury in zebrafish. Motor neurons and different types of
interneurons are generated from radial glial cells in the region
adjacent to the injury site [120]. It has been demonstrated that
some newly generated motor neurons may even be capable
of connecting with their peripheral muscle targets, indicative
of effective integration into the existing spinal network [121].
However, since this only applies to a small number of new-
born motor neurons, it remains uncertain whether regen-
erative neurogenesis significantly contributes to functional
recovery [122].
Damage to the zebrafish spinal cord induces an acute
inflammatory response, including the activation of microglia
and monocyte-derived macrophages [123, 124]. However, its
functional contribution to the regenerative process remains
largely unexplored [125] (Figure 1(d)). One study reports that
lysophosphatidic acid has proinflammatory but antiregener-
ative effects after spinal cord injury, in zebrafish as well as
in mice [126]. However, this does not completely rule out
the possibility of a beneficial role of inflammatory cells, since
their phenotype can differ upondifferent types of stimulation,
as described above. Besides, it has been demonstrated that
zebrafish Ptena negatively affects regeneration after spinal
cord injury, a finding that mirrors the observations in
mammals [127] and can be linked to inflammatory pathways,
as described above. Lastly, in a model of motor neuron abla-
tion in larval zebrafish, in which motor neurons regenerate
from spinal progenitor cells, the microglia/macrophages that
gather at the lesion site are suggested to play a beneficial
role during regeneration. Indeed, suppressing the immune
response via treatment with dexamethasone, a synthetic glu-
cocorticoid with anti-inflammatory effects [128] significantly
suppresses motor neuron regeneration [129]. Yet, in-depth
characterization of the role of acute inflammation in zebrafish
spinal cord regeneration is lacking.
3.3. Acute Inflammation in Other Zebrafish Regenerative
Models. Neuroinflammation has been put forward as an
important underpinning of successful regeneration in other
zebrafish CNS injurymodels as well. In contrast tomammals,
in which a stab injury in the CNS is followed by massive neu-
ronal cell death, reactive gliosis, and the eventual formation
of a growth-inhibiting glial scar [28, 130–132], zebrafish can
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recover from such a lesion. Although cell death and reactive
proliferation of microglia, oligodendrocytes, and other cells
are observed in zebrafish as well, this resolves quickly and no
evidence of glial scar tissue can be found [28, 29, 132]. Fur-
thermore, zebrafish are able to initiate massive regenerative
neurogenesis to compensate for the lost neurons.These newly
generated neurons derive from proliferating radial glia cells
[133]. Importantly, it has been proposed that acute neuroin-
flammation acts as a beneficial regulator of de novo neuro-
genesis in zebrafish. Systemic treatment with dexamethasone
reduces the number of microglia/macrophages at the lesion
site, coinciding with a diminished proliferation of radial
glia and less newborn neurons, thus preventing regeneration
after stab injury to the telencephalon [29]. Furthermore,
the leukotriene signaling pathway appears to be a pivotal
component of the inflammatory reaction and leukotriene
C4 (LTC4), which signals through the cysteinyl leukotriene
receptor 1 (CysLT1), is found to be necessary and sufficient
for the initiation of neural progenitor proliferation and sub-
sequent neurogenesis. Conclusively, inflammation appears to
positively affect the reparative capacities in the zebrafish CNS
[28, 29, 134, 135].
3.4. Macrophage Polarization in Zebrafish. Recently, M1- and
M2-like macrophage subsets have also been observed in
zebrafish. They express some of the markers that are typical
for their mammalian counterparts. After caudal fin ampu-
tation or bacterial infection in larval fish, these macrophage
phenotypes are activated in a time-dependent manner. Mir-
roring successful wound healing in mammals, monocyte-
derived macrophages are recruited to the site of injury, where
they first adopt a proinflammatory M1-like phenotype. In a
later stage, this phenotype is progressively converted to M2-
like, encompassing intermediate phenotypes in which both
M1 and M2 markers are expressed [136]. This sequential M1-
M2 response is supposed to be optimal for regeneration and
contrasts the overwhelming presence of proinflammatory
M1 microglia/macrophages observed after CNS injuries
in mammals. Although supporting evidence from other
zebrafish regeneration models is still needed, this study pro-
vides a first indication of functional similarities of microglia/
macrophages in zebrafish and mammals.
4. The Impact of Inflammaging
To date, most studies aiming at the induction of CNS
regeneration in mammals have been performed in young
adult animals.However, the effect of aging on the regenerative
mechanisms should not be overlooked. The limited regener-
ative capacity of the adult mammalian CNS further declines
upon aging, and aging processes compromise the implemen-
tation of therapeutic strategies [137]. This is a major concern,
especially since aging is one of themost important risk factors
for many neurodegenerative diseases, and regenerative ther-
apies are therefore most needed in elderly. Importantly, the
immune system is subjected to aging as well, adding another
level of complexity to this issue. Here, we will focus on the
physiology of microglia and blood-borne macrophages in an
aging context, and the consequences for repair after CNS
injury.
4.1. Inflammaging in Mammals. It is well recognized that
mammalian aging is accompanied by a low-grade, chronic
proinflammatory state, which is also referred to as “inflam-
maging” and can be considered as amanifestation of immun-
osenescence [34, 138, 139]. Inflammaging is a systemic phe-
nomenon that also affects the CNS. In the rodent retina,
it is associated with morphological changes and functional
impairments of microglia [32, 140]. This includes a slight but
significant increase in microglial cell density, which is also
observed in some other brain regions [141, 142], but not in
all [143, 144]. One explanation for this phenomenonmight be
a reduced functionality of individual microglia, resulting in
the necessity for more cells [32, 145]. Secondly, the ordered
distribution of microglia throughout the retina seems to be
deteriorating upon aging: they migrate from the inner retina
towards the periphery and accumulate in the subretinal space,
which is normally devoid of microglia [141, 142]. In addition,
aged retinal microglia show reduced arborisation and slower
process motilities, which likely compromise their dynamic
surveying behaviour, further suggesting functional defects
[141]. As similar observations are made in other brain regions
as well [146, 147], there is increasing evidence for an age-
related decline in the ability of microglia to perform their
normal tasks in the CNS.
In addition, microglia develop age-related changes in
their immune physiology. Evidence suggests that they
adopt an altered, more inflammatory status, associated with
increased expression of activationmarkers and proinflamma-
tory cytokines [32]. This phenomenon has also been referred
to as microglial sensitization or “priming.” Indeed, the
microglial responsiveness to stressors or damage cues from
the local environment or the periphery is increased in aged
individuals, and the resulting inflammatory reaction is more
pronounced than in young adults [148, 149]. Thus, although
seemingly contradictory, the functional impairments associ-
ated with microglial senescence may be accompanied by an
exaggerated response to stress or injury because of microglial
priming [149]. Of importance, these age-related changes in
microglial function may render the CNS more vulnerable to
neurodegeneration, but may also highly impact regenerative
abilities [33, 150].
4.2. The Impact of Inflammaging on Mammalian CNS Regen-
eration. As a result of microglial priming, detrimental effects
of the immune response upon injury may be promoted in
aged individuals, thereby suppressing the beneficial aspects of
inflammation and further restricting regenerative capacities.
Some studies have already provided evidence for this hypoth-
esis in different injury models. Firstly, after traumatic brain
injury, the microglial response was indeed found to be more
pronounced and prolonged in aged mice compared to young
adults [151]. Another study shows that traumatic brain injury
results in larger lesions in aged mice. Alongside, the immune
activation is exaggerated, and an increased ratio of pro- to
anti-inflammatory microglia/macrophages has been demon-
strated [152]. Secondly, reduced functional recovery upon
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aging is also observed after spinal cord injury in mice and
has been correlated with impairments in the induction of IL-
4 receptor 𝛼 (IL-4R𝛼) expression in microglia. The authors
suggest that the impaired recovery in aged mice is related to
a reduced responsiveness of microglia/macrophages to IL-4
and thus a shift towards a proinflammatory cytokine activa-
tion [153]. Recently, this research group also demonstrated
an age-related decline in macrophage IL-10 expression after
spinal cord injury. Since IL-10 is a key indicator of M2-like
activation, this points to a reduction in the number of anti-
inflammatory macrophages, and thus a disrupted balance
between macrophage phenotypes, which presumably under-
lies the observed impairment in functional recovery with age
[154]. Lastly, age-related deteriorations of microglia have also
been found after damage to the retina. In a laser-induced
injury model, senescent microglia respond more slowly; that
is, their process motility and migration rate are reduced. In
addition, senescentmicroglia remain present at the injury site
for a longer time period than in their young adult counter-
parts, indicating that resolution of the inflammatory reaction
is retarded upon aging. Unfortunately, age-related differences
in injury severity and functional recovery were not addressed
in this study [141]. Conclusively, aging of microglia and
blood-derivedmacrophages undoubtedly affects the regener-
ative capacity after CNS injuries.
4.3. The Effect of Inflammaging on the Zebrafish Regenerative
Potential. Recently, the zebrafish has emerged as a valuable
model for human aging. Substantial evidence points towards
the presence of aging hallmarks in zebrafish, also in the CNS
(reviewed by [35]). Therefore, it is an attractive model organ-
ism to shed light on the relationship between aging and regen-
erative capacities. An age-dependent decline in the regener-
ative capacity of the spinal cord has already been suggested
[155], based on early findings in goldfish [156]. However, a
comprehensive study of the effect of aging on axonal regen-
eration in the zebrafish CNS is still lacking, and the impact of
inflammation herein has not yet been investigated. Currently,
the only evidence that age-related alterations in the immune
system may potentially underlie a diminished regenerative
capacity in senescent fish comes from a model of optic
nerve remyelination. Of note, in both rodents and zebra-
fish, the ability to restore myelin sheaths is high in young
individuals but decreases upon aging. It has been suggested
that after optic nerve demyelination in aged zebrafish,
the reduced remyelination is a result of an impaired
response ofmicroglia/macrophages. Indeed, whilemicroglia/
macrophages are recruited to the lesion site in young adults
at four days after injury, their number at this time point is
not significantly different from the naive condition in aged
fish [157]. Overall, although an association between altered
inflammation and attenuated regeneration upon aging has
already been put forward, the impact of (inflamm)aging on
the normally flawless regenerative process in the zebrafish
CNS is scarcely studied and awaits further in-depth charac-
terization.
5. Conclusion
Over the past years, neurodegenerative diseases and CNS
trauma have been a major focus on neuroscience research,
with many studies dedicated to the elucidation of the cel-
lular and molecular changes that underlie their pathology.
The innate immune system is undoubtedly involved in the
pathogenesis of many of these CNS conditions, yet increasing
evidence suggests that it can also beneficially contribute
to the regenerative process. Indeed, a balanced activity of
inflammatory cell types, of which microglia and blood-
borne macrophages are the most studied, has been shown to
improve morphological and functional recovery after injury
in optic nerve and spinal cord injury models.
Unlike mammals, zebrafish possess a powerful regener-
ative capacity after CNS lesions, which leads to successful
repair and seems to coincide with a favourable inflammatory
state. Further uncovering of the mechanisms that control
inflammatory and regenerative processes might provide
fruitful insights that may lead to the identification of innova-
tive therapeutic targets for human patients.
Noteworthy, we foresee that an important hurdlewill have
to be taken in the development of novel CNS regenerative
strategies from bench to bedside, being the fact that aging
processes affect the already limited regenerative potential in
mammals. Since the innate immune system is subjected to
aging as well, it is assumed to react differently to injuries in
aged individuals. Increasing evidence for a detrimental effect
of inflammaging on the regenerative outcome is emerging,
but further in-depth characterization in both mammals and
zebrafish is highly warranted.
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